FDA Orange Book
Is there a generic for Vocabria?
Vocabria contains cabotegravir. Orange Book status for every listed strength, the approved generic makers, and the listed patents and exclusivities.
Source: FDA Orange Book data file dated 2026-10-09. Publisher page
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vocabria (cabotegravir). The Orange Book shows its last listed patent expires February 4, 2031 and its last listed exclusivity ends January 21, 2026.
Run it in Rivvi
Map Vocabria and your other top fills to their generics
Every strength in RxNorm, with brands that have no generic flagged.
Build the mapFree to start. Opens Rivvi, the AI workspace for healthcare teams.
Vocabria products in the Orange Book
| Form and route | Strength | Brand status | Brand TE | Active generics | Generic TE codes |
|---|---|---|---|---|---|
| tablet, oral | EQ 30MG BASE | Marketed (Rx) | None | 0 | None |
NDA 212887, held by VIIV HEALTHCARE CO. Active generics are ANDA products in the Orange Book prescription list with the same ingredient, dosage form, route and strength.
Vocabria patents
| Patent | Expires | Covers | Use code | NDA |
|---|---|---|---|---|
| 10927129 | April 28, 2026 | Drug substance, Drug product | None | 212887 |
| 8410103 | February 4, 2031 | Drug substance, Drug product | U-3348 | 212887 |
Vocabria exclusivity
| Code | Meaning | Expires | NDA |
|---|---|---|---|
| NCE | New chemical entity | January 21, 2026 | 212887 |
Vocabria NDC codes
Questions
Is there a generic for Vocabria?
No. The Orange Book lists no active FDA-approved generic (ANDA) for Vocabria (cabotegravir). The Orange Book shows its last listed patent expires February 4, 2031 and its last listed exclusivity ends January 21, 2026.
What is the generic name for Vocabria?
The active ingredient in Vocabria is cabotegravir, per the FDA Orange Book.
When does the Vocabria patent expire?
The last patent listed for Vocabria in the Orange Book expires February 4, 2031. A listed patent expiry date is not a generic launch date.
What does a therapeutic equivalence code mean?
In the Orange Book, codes that start with A (such as AB) mean FDA considers the product therapeutically equivalent to the reference drug. Codes that start with B mean FDA does not, at this time, consider the product therapeutically equivalent.